Stem cell pioneer James Thomson and two other University of Wisconsin-Madison researchers have received a $2.2 million, two-year federal grant that is part of an initiative to improve the process for predicting whether potential new drugs are safe in humans. Read full Journal Sentinel story here.
- Isthmus: The comeback crop – Hemp farming returns and it promises big rewardsFebruary 21, 2019
- InsideWis: For hospital price shopping, Wisconsin solution better than new federal fixFebruary 21, 2019
- Emerging companies: Feb. 20 at midnight deadline to meet with major firms at Tech Summit meetingsFebruary 20, 2019
- ‘Office hours’ offer expert advice for emerging firms at March 18 Lambeau Tech SummitFebruary 19, 2019
- WisBiz: The Show’ covers Tech Metrics, Tom Still commentary; interview with Sean RobertsFebruary 18, 2019